Skip to content

10x Genomics, Inc. TXG Restructuring charges, net of cash paid (Note 15)

Restructuring charges, net of cash paid (Note 15) at other companies

Johnson Controls International logo
Johnson Controls InternationalJCI
$57M-46.6%
PepsiCo logo
PepsiCoPEP
$133M-37.6%
Moody's logo
Moody'sMCO
$1M-66.7%
Warner Bros. Discovery, Inc. logo
Warner Bros. Discovery, Inc.WBD
$0-100%
Coherent logo
CoherentCOHR
$20.82M-15.5%
American Tower logo
American TowerAMT
$20.75M-14.1%

Other financials

Income statement

See full
Revenue$150.8M-2.6%
Gross profit$106.2M+0.7%
Operating income-$17.0M+56.7%
Net income-$13.5M+60.8%
EPS (diluted)-$0.10+64.3%

Balance sheet

See full
Cash & equivalents$490.3M+30.0%
Total debt$81.4M+1.6%
Total equity$814.3M+15.2%
Total assets$1.0B+12.4%

Cash flow

See full
Operating cash flow$26.1M-24.0%
CapEx$1.6M-15.6%
Free cash flow$24.5M-24.4%

Valuation

See full
Market cap$4.41B+154%

Profitability

See full
Gross margin69.6%+1.2pp
Operating margin-6.1%-2.7pp
Net margin-3.5%-1.6pp
FCF margin19.1%

Returns & leverage

See full
Return on equity-3%-1.4pp
Debt / equity0.1×0.0×
Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCostsAndAssetImpairmentCharges.

The official record: 10x Genomics, Inc.’s 10-K, filed February 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s restructuring charges, net of cash paid (note 15).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 10x Genomics, Inc.'s restructuring charges, net of cash paid (note 15)?
10x Genomics, Inc. (TXG) reported restructuring charges, net of cash paid (note 15) of $313.25K in Q4 2025.